Usana Health Sciences Inc (NYSE:USNA) currently has a daily average trading volume of 99.58K but it saw 97628 shares traded in last market. With a market cap of 665.94M USD, the company’s current market price of $34.94 came falling about -1.08 while comparing to the previous closing price of $35.32. In past 52 weeks, the stock remained buoying in the range of price level as high as $52.75 and as low as $31.44. In the recent trading on the day, stock has struck highest price mark of $34.115 while lowest mark touched by it was $34.97.
Taking a look at 20-day trading activity of Usana Health Sciences Inc (USNA) gives us an average price of $35.87, while its current price level is -33.76% below from 52-week high level whereas it is 11.13% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $37.73 while that of 200 days or SMA-200 reads an average of $41.46. A closer look into the stock’s movement over the week reveals that its volatility is standing at 2.93% during that period while stretching the period over a month that increases to 3.81%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 42.23 which implies that the stock is in neutral territory.
Jefferies downgraded its recommendation for the stock as a “Underperform” from “Hold” on July 07, 2022 while assigning a price target range of $78-$53. DA Davidson also issued its recommendations for the stock as it initiated the price target for the stock is $86.
Over the week, USNA’s stock price is moving -2.65% down while it is -6.35% when we observe its performance for the past one month. Year-to-date it is -2.65% down and over the past year, the stock is showing a downside performance of -31.53%.
Currently, Usana Health Sciences Inc’s total number of outstanding shares is 19.06M. Company’s return on investment (ROI) stands at 10.19% and return on equity (ROE) at 10.83%. It has a price to earnings ratio (P/E ratio) of 12.36 while having a 12.35 of forward P/E ratio. Stock’s beta reads 0.88. Stock has a price to book (P/B) ratio of 1.25 while price to sale or P/S ratio amounts to 0.77. Its return on asset (ROA) is 8.54% on average.
